The SetPoint System as a Pro-Remyelination Therapy for Relapsing-Remitting Multiple Sclerosis: A Pilot Study

Sponsored by SetPoint Medical Corporation

Interested in joining? Eligibility criteria and contact info are on ClinicalTrials.gov.

View on ClinicalTrials.gov

Target enrollment

U.S. states

Mar 2026

Start date

Sep 2030

Expected completion

Interventions / Treatments

Procedure/Surgery: Implant ProcedureDisease-Modifying Therapies (DMTs)Device: Active stimulationDevice: Non-active stimulation

Conditions studied

Relapsing Remitting Multiple Sclerosis

Where this trial is running (4 sites)

Georgia1 site

Atlanta

Minnesota1 site

Plymouth

Washington1 site

Seattle

West Virginia1 site

Morgantown

Participating MS centers on MS Buddy (3)

UW Medicine Multiple Sclerosis Center
Seattle, WA

The Minnesota Center for MS
Plymouth, MN

Andrew C. Carlos MS Institute at Shepherd
Atlanta, GA

MS centers in Georgia

Compare treatment centers near a trial site — patient experience, providers, and care ratings.

View Georgia centers

More NA trials

Browse all NA MS trials

Check out the MS Buddy App

Track symptoms, monitor wellness, and stay on top of your MS care. It's free, no ads. How? It's made and supported by MS patients who get their ideas from other MS patients.